Do you want to read an article? Please log in or register.
High ten-year remission rates following rituximab, fludarabine, mitoxantrone and dexamethasone (R-FND) with interferon maintenance in indolent lymphoma: Results of a randomized Study
LymphomaMultiple Myeloma (MM)